Talat Mahmood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Talat Mahmood has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Mounir Ibrahim
Department Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia
2 shared publications - Benjamin J. C. Quah
Irradiation Immunity Interaction Lab, Division of Genome Sciences and Cancer, John Curtin School of Medical Research, Australian National University, Australia
1 shared publication - Farhan Syed
Irradiation Immunity Interaction Lab, ACRF Department of Cancer Biology and Therapeutics, Canberra, ACT, Australia
1 shared publication - Graham Rhall
The John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia
1 shared publication - Grant Buchanan
Irradiation Immunity Interaction Lab, ACRF Department of Cancer Biology and Therapeutics, Canberra, ACT, Australia
1 shared publication - Hany Elsaleh
Department of Radiation Oncology, UCLA, Los Angeles, CA, USA
1 shared publication
Latest Publications
- Open Access
- 18 March 2025
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 48 (2) , 635-647
Characteristics of the electron beam outside the applicator in an Elekta Versa HD Linac
Radiotherapy is an essential component of cancer treatment, but healthy tissues can be exposed to out-of-field doses, potentially causing adverse effects and secondary cancers. This study investigates peripheral doses outside the electron beam applicator in an Elekta Versa HD linear accelerator. Peripheral doses outside an electron applicator were measured using 6, 9, and 12 MeV beams at their respective maximum dose depths while maintaining a 100 cm source-to-surface distance. Measurements employed EBT3 films within Plastic Water DT phantoms. The influence of field size on penumbra width and peripheral doses were examined using various cutouts (6 × 6 cm², 10 × 10 cm², and a 5 cm diameter circle) within a 10 × 10 cm² applicator, with gantry and collimator angles set to 0 degrees. Additionally, the impact of collimator angles on penumbra width and peripheral doses was explored, enhancing the understanding of dose distribution. Measured profiles were also compared with those calculated using Monaco treatment planning system. Findings showed that both penumbra width and peripheral dose values increased with energy across different field sizes and collimator angles. Root Mean Square Deviation (RMSD) analysis indicated deviations of 1.8 mm for penumbra and 1.1% for peripheral doses between measured profiles and Treatment Planning System (TPS) predictions for all field sizes. Peripheral doses remained below 5% of the maximum dose at distances ranging from 10 to 15 mm away from the field edges, indicating acceptable tolerance levels (ICRU report 24). However, further dose reduction may be possible with additional shielding to keep doses as low as reasonably achievable. This study highlights the critical importance of considering peripheral doses in radiotherapy, emphasizing the need to evaluate the impact on healthy tissues outside the primary treatment area to ensure patient safety and mitigate long-term treatment-related side effects. The findings underscore the necessity of implementing appropriate measures to minimize peripheral doses.
- 18 March 2025
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 48 (2) , 635-647
Open AccessCharacteristics of the electron beam outside the applicator in an Elekta Versa HD Linac
Radiotherapy is an essential component of cancer treatment, but healthy tissues can be exposed to out-of-field doses, potentially causing adverse effects and secondary cancers. This study investigates peripheral doses outside the electron beam applicator in an Elekta Versa HD linear accelerator. Peripheral doses outside an electron applicator were measured using 6, 9, and 12 MeV beams at their respective maximum dose depths while maintaining a 100 cm source-to-surface distance. Measurements employed EBT3 films within Plastic Water DT phantoms. The influence of field size on penumbra width and peripheral doses were examined using various cutouts (6 × 6 cm², 10 × 10 cm², and a 5 cm diameter circle) within a 10 × 10 cm² applicator, with gantry and collimator angles set to 0 degrees. Additionally, the impact of collimator angles on penumbra width and peripheral doses was explored, enhancing the understanding of dose distribution. Measured profiles were also compared with those calculated using Monaco treatment planning system. Findings showed that both penumbra width and peripheral dose values increased with energy across different field sizes and collimator angles. Root Mean Square Deviation (RMSD) analysis indicated deviations of 1.8 mm for penumbra and 1.1% for peripheral doses between measured profiles and Treatment Planning System (TPS) predictions for all field sizes. Peripheral doses remained below 5% of the maximum dose at distances ranging from 10 to 15 mm away from the field edges, indicating acceptable tolerance levels (ICRU report 24). However, further dose reduction may be possible with additional shielding to keep doses as low as reasonably achievable. This study highlights the critical importance of considering peripheral doses in radiotherapy, emphasizing the need to evaluate the impact on healthy tissues outside the primary treatment area to ensure patient safety and mitigate long-term treatment-related side effects. The findings underscore the necessity of implementing appropriate measures to minimize peripheral doses.
- Open Access
- 1 November 2020
- Published by Oxford University Press (OUP) in BJR|Open
- Vol. 2 (1) , 20190045
Custom-designed Small Animal focal iRradiation Jig (SARJ): design, manufacture and dosimetric evaluation
Objective: Preclinical animal models allow testing and refinement of novel therapeutic strategies. The most common preclinical animal irradiators are fixed source cabinet irradiators, which are vastly inferior to clinical linear accelerators capable of delivering highly conformal and precise treatments. The purpose of this study was to design, manufacture and test an irradiation jig (small animal focal irradiation jig, SARJ) that would enable focal irradiation of subcutaneous tumours in a standard fixed source cabinet irradiator. Methods and materials: A lead shielded SARJ was designed to rotate animal holders about the longitudinal axis and slide vertically from the base plate. Radiation dosimetry was undertaken using the built-in ion chamber and GAFChromic RTQA2 and EBT-XD films. Treatment effectiveness was determined by irradiating mice with subcutaneous melanoma lesions using a dose of 36 Gy in three fractions (12 Gy x 3) over three consecutive days. Results: The SARJ was tested for X-ray shielding effectiveness, verification of dose rate, total dose delivered to tumour and dose uniformity. Accurate and uniform delivery of X-ray dose was achieved. X-ray doses were limited to the tumour site when animal holders were rotated around their longitudinal axis to 15o and 195o, allowing sequential dose delivery using parallel-opposed tangential beams. Irradiation of subcutaneous melanoma tumour established on the flanks of mice showed regression. Conclusion: SARJ enabled delivery of tangential parallel-opposed radiation beams to subcutaneous tumours in up to five mice simultaneously. SARJ allowed high throughput testing of clinically relevant dose delivery using a standard cabinet-style fixed source irradiator. Advances in knowledge: A custom designed jig has been manufactured to fit into conventional cabinet irradiators and is dosimetrically validated to deliver clinically relevant dose distributions to subcutaneous tumours in mice for preclinical studies.
- 1 November 2020
- Published by Oxford University Press (OUP) in BJR|Open
- Vol. 2 (1) , 20190045
Open AccessCustom-designed Small Animal focal iRradiation Jig (SARJ): design, manufacture and dosimetric evaluation
Objective: Preclinical animal models allow testing and refinement of novel therapeutic strategies. The most common preclinical animal irradiators are fixed source cabinet irradiators, which are vastly inferior to clinical linear accelerators capable of delivering highly conformal and precise treatments. The purpose of this study was to design, manufacture and test an irradiation jig (small animal focal irradiation jig, SARJ) that would enable focal irradiation of subcutaneous tumours in a standard fixed source cabinet irradiator. Methods and materials: A lead shielded SARJ was designed to rotate animal holders about the longitudinal axis and slide vertically from the base plate. Radiation dosimetry was undertaken using the built-in ion chamber and GAFChromic RTQA2 and EBT-XD films. Treatment effectiveness was determined by irradiating mice with subcutaneous melanoma lesions using a dose of 36 Gy in three fractions (12 Gy x 3) over three consecutive days. Results: The SARJ was tested for X-ray shielding effectiveness, verification of dose rate, total dose delivered to tumour and dose uniformity. Accurate and uniform delivery of X-ray dose was achieved. X-ray doses were limited to the tumour site when animal holders were rotated around their longitudinal axis to 15o and 195o, allowing sequential dose delivery using parallel-opposed tangential beams. Irradiation of subcutaneous melanoma tumour established on the flanks of mice showed regression. Conclusion: SARJ enabled delivery of tangential parallel-opposed radiation beams to subcutaneous tumours in up to five mice simultaneously. SARJ allowed high throughput testing of clinically relevant dose delivery using a standard cabinet-style fixed source irradiator. Advances in knowledge: A custom designed jig has been manufactured to fit into conventional cabinet irradiators and is dosimetrically validated to deliver clinically relevant dose distributions to subcutaneous tumours in mice for preclinical studies.